Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $28.73 | Nov 18, 2024 | Direct |
Dyne Therapeutics, Inc. | Director | Stock option (right to buy) | 22.7K | Nov 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DYN | Dyne Therapeutics, Inc. | Nov 18, 2024 | 3 | -$331K | 4 | Nov 18, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | May 22, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
DYN | Dyne Therapeutics, Inc. | Mar 2, 2022 | 1 | $0 | 4 | Mar 4, 2022 | Director |
DYN | Dyne Therapeutics, Inc. | Mar 2, 2022 | 0 | $0 | 3 | Mar 4, 2022 | Director |